Clinical trial
A Prospective, Randomized and Controlled Multi-center Study of Geistlich Fibro-Gide® Compared With Connective Tissue Graft for Soft Tissue Volume Augmentation Around Dental Implants
NCT04703738 is registered in ClinicalTrials.gov with Geistlich Pharma AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized and Controlled Multi-center Study of Geistlich Fibro-Gide® Compared With Connective Tissue Graft for Soft Tissue Volume Augmentation Around Dental Implants
- Lead sponsor
- Geistlich Pharma AG
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 13, 2018
- Completion date
- May 12, 2026
- Enrollment
- 60 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
soft tissue defect